MENU
+Compare
INCR
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$1.48
Change
+$0.14 (+10.45%)
Capitalization
123.5M

INCR Intercure Ltd Forecast, Technical & Fundamental Analysis

a provider of outsourced clinical development and commercialization services to biopharmaceutical companies

INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for INCR with price predictions
Dec 20, 2024

INCR saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for INCR moved out of overbought territory on December 19, 2024. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 44 similar instances where the indicator exited the overbought zone. In of the 44 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INCR entered a downward trend on November 26, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INCR's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 20, 2024. You may want to consider a long position or call options on INCR as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INCR just turned positive on November 25, 2024. Looking at past instances where INCR's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCR advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.928) is normal, around the industry mean (57.958). P/E Ratio (22.519) is within average values for comparable stocks, (89.727). INCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.145) is also within normal values, averaging (19.472).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INCR is expected to report earnings to fall 174.53% to 0 cents per share on April 07

Intercure Ltd INCR Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.01
Q1'24
Beat
by $0.08
Q4'23
Missed
by $0.30
The last earnings report on November 12 showed earnings per share of -1 cents, missing the estimate of 0 cents. With 294.75K shares outstanding, the current market capitalization sits at 123.50M.
A.I. Advisor
published General Information

General Information

a provider of outsourced clinical development and commercialization services to biopharmaceutical companies

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
85 Medinat ha-Yehudim Street
Phone
+972 774605012
Employees
370
Web
https://www.intercure.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYHBF0.250.02
+9.36%
Skyharbour Resources Ltd.
BNTGY11.880.09
+0.76%
Brenntag SE
BRDCY16.810.07
+0.42%
Bridgestone Corp.
SFRGY3.480.01
+0.14%
Salvatore Ferragamo S.P.A.
EADSY40.42-0.04
-0.10%
Airbus SE

INCR and Stocks

Correlation & Price change

A.I.dvisor tells us that INCR and KMDA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+11.19%
KMDA - INCR
31%
Poorly correlated
+0.85%
SNDL - INCR
25%
Poorly correlated
+4.05%
DVAX - INCR
23%
Poorly correlated
-0.31%
SUPN - INCR
23%
Poorly correlated
-0.95%
QNTM - INCR
23%
Poorly correlated
-13.29%
More